TrialBritish journal of cancer2013

KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer.

K G Spindler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.